Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Neal davidson who wrote (793)	5/17/1999 4:23:00 PM
From: StockMiser	Read Replies (2) of 2344

At the time that I wrote that, the stock price was being supported by several MM's, keeping it in a tight range. Once they left...the price dropped (just as I had mentioned it would). It wasn't speculation...just direct observation. I personally watched USCT pick up around 80K shares, all above $5. I was neither a buyer nor seller today (as was the case of many longs). I'm still awaiting further exposure for BIOM. The results of Theratope study used for stem cell replacement patients were nothing short of spectacular - it doubled life expectancy. I seriously expect this particular study to gain further exposure over the next week or so. Let me also remind you that the CEO was, in fact, interviewed by the NY Times - that is NOT a rumor. That the article will appear in conjunction with the ASCO was the rumor. In any case, I am in for the long haul. BIOM's time will come...and I don't think we'll have to wait much longer. The word is slowly getting out there... SM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next